US Broker Ratings

Regencell Bioscience Holdings (RGC): Navigating Volatility in the Healthcare Sector

Regencell Bioscience Holdings Limited (RGC), a Hong Kong-based company specializing in Traditional Chinese Medicine (TCM), is carving out a niche in the healthcare sector with a focus on neurocognitive disorders,..

Edwards Lifesciences Corporation (EW) Stock Analysis: A Healthcare Powerhouse with a 6.77% Upside Potential

Edwards Lifesciences Corporation (NYSE: EW), a leader in the medical devices sector, continues to capture investor interest with its advanced cardiovascular solutions. With a market capitalization of $52.27 billion, the..

Illumina, Inc. (ILMN) Stock Analysis: Navigating the Ups and Downs of a Genomics Leader

Illumina, Inc. (NASDAQ: ILMN) is a heavyweight in the healthcare sector, specifically within the diagnostics and research industry. With a substantial market capitalization of $26.71 billion, the company is a..

Bausch + Lomb Corporation (BLCO)

⚠️ No article content returned.

..

Medtronic plc (MDT) Stock Analysis: Exploring a 21% Potential Upside for Investors

Medtronic plc (NYSE: MDT), a titan in the healthcare sector specializing in medical devices, continues to draw investor attention with its diverse portfolio and robust financial metrics. Headquartered in Galway,..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Capturing 24.84% Potential Upside in Healthcare Innovation

Merit Medical Systems, Inc. (NASDAQ: MMSI), a prominent player in the healthcare sector, is making waves in the medical instruments and supplies industry with a market capitalization of $4.28 billion...

BioMarin Pharmaceutical Inc. (BMRN): Investor Outlook with a 48.89% Potential Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) stands out in the biotechnology sector with a focus on developing therapies for rare and life-threatening diseases. With a current market capitalization of $11.4 billion,..

BrightSpring Health Services, I (BTSG): Strong Buy Ratings Signal Investor Confidence Despite Valuation Challenges

BrightSpring Health Services, Inc. (BTSG) is making waves in the healthcare sector with its robust platform offering home and community-based healthcare services. Operating primarily in the United States, BrightSpring provides..

Tenet Healthcare Corporation (THC) Stock Analysis: Unlocking a 28.67% Potential Upside in the Healthcare Sector

For investors seeking opportunities in the healthcare sector, Tenet Healthcare Corporation (NYSE: THC) presents a compelling case. With a potential upside of 28.67% based on current analyst ratings, Tenet Healthcare..

Sanofi (SNY) Stock Analysis: A Compelling 30% Upside Potential Amidst Strong Dividend Yield

Sanofi (NASDAQ: SNY), a stalwart in the global healthcare sector, continues to capture investor attention with its robust dividend yield and promising growth potential. With a market capitalization of $102.81..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Unveiling a Promising 50% Upside Potential

iRhythm Holdings, Inc. (NASDAQ: IRTC) has been making waves in the healthcare sector, particularly within the medical devices industry, with its innovative cardiac monitoring solutions. As a digital healthcare company..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: A Biotech with Promising Upside and Strong Buy Ratings

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is making waves in the biotechnology sector, capturing investor attention with its promising pipeline focused on rare neuroendocrine diseases. With a current market capitalization of..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Navigating a 15.35% Upside Potential in the Healthcare Sector

Neurocrine Biosciences, Inc. (NBIX) is capturing investor attention with a compelling upside potential of 15.35%, positioning itself as a promising player in the healthcare sector, specifically within the specialty and..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: A 32% Upside Opportunity in the Biotech Sector

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a dynamic player in the biotechnology sector, offers investors a compelling opportunity with a potential upside of 32.39%. Specializing in novel therapeutics for metabolic dysfunction-associated..

Humana Inc. (HUM) Stock Analysis: Evaluating Growth Amidst a Stretched Valuation

Humana Inc. (NYSE: HUM), a stalwart in the healthcare plans industry, boasts a market capitalization of $46.08 billion, marking its prominence within the United States’ healthcare sector. Despite its impressive..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating the Healthcare Device Sector with Strategic Growth

Integer Holdings Corporation (NYSE: ITGR) stands as a formidable entity in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $3.19 billion, this Texas-based company..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A Biotech Powerhouse with a Potential 49.75% Upside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a trailblazer in the biotechnology sector, is making waves with its innovative RNA interference therapeutics. With a market capitalization of $38.9 billion, the company is..

Qiagen N.V. (QGEN) Stock Analysis: Exploring an 11.55% Potential Upside in the Healthcare Sector

As a key player in the healthcare sector, Qiagen N.V. (NYSE: QGEN) stands out with its robust offerings in the diagnostics and research industry. With a market capitalization of $8.13..

Revvity, Inc. (RVTY) Stock Analysis: Navigating the Diagnostics & Research Sector with a $12.61 Billion Market Cap

Revvity, Inc. (NYSE: RVTY), a prominent player in the healthcare sector, offers a compelling investment narrative within the diagnostics and research industry. Renowned for its cutting-edge health sciences solutions, Revvity..

Ionis Pharmaceuticals, Inc. (IONS) Investor Outlook: Strong Buy Ratings and 30% Upside Potential

Ionis Pharmaceuticals, Inc. (IONS), a leading player in the biotechnology sector, is offering investors a compelling opportunity with its innovative RNA-targeted medicines. With a market capitalization of $13.42 billion, Ionis..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds